Raymond James Financial’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.2M Sell
672,660
-228,948
-25% -$11.6M 0.01% 1202
2026
Q1
$48.1M Buy
901,608
+247,278
+38% +$14.5M 0.01% 873
2025
Q4
$40.7M Buy
654,330
+21,022
+3% +$1.3M 0.01% 945
2025
Q3
$38M Sell
633,308
-46,515
-7% -$2.85M 0.01% 979
2025
Q2
$42.6M Sell
679,823
-76,920
-10% -$4.62M 0.01% 852
2025
Q1
$45.5M Buy
756,743
+90,139
+14% +$5.6M 0.02% 767
2024
Q4
$38.9M Buy
+666,604
New +$39.6M 0.01% 875

Other funds holding IHI

Raymond James Financial's IHI Position: Q2 2026 in Review

Raymond James Financial reduced its iShares US Medical Devices ETF (IHI) stake by 25% in Q2 2026, selling an estimated $11.6M and leaving 672,660 shares worth $33.2M. The position accounts for 0.01% of the portfolio, ranked #1202.

Raymond James Financial first reported a position in IHI in Q4 2024 and has held it in 7 quarters since. The position peaked at $48.1M in Q1 2026. 502 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Raymond James Financial held 672,660 shares of iShares US Medical Devices ETF worth $33.2M as of Q2 2026.
  • Raymond James Financial sold 228,948 iShares US Medical Devices ETF shares in Q2 2026, an estimated $11.6M.
  • iShares US Medical Devices ETF made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #1202 holding.
  • Raymond James Financial first reported a position in iShares US Medical Devices ETF in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's iShares US Medical Devices ETF position peaked at $48.1M in Q1 2026.
  • 502 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.